Senores Pharmaceuticals IPO Vs Ventive Hospitality IPO: Which issue will list with higher gains?

As the calendar year 2024 draws to a close, the primary market continues its stellar run with a flurry of activity. Amongst the three mainboard IPOs that are going to list today (December 30), two issues are in the spotlight – Senores Pharmaceuticals and Ventive Hospitality with much speculation on which issue might deliver better gains.

Although both companies come from different sectors and carry their own market dynamics, let’s take a look at the key details of the issue and their potential listing performance.

Grey Market Premium: What Does It Indicate?

The grey market premium (GMP) is often seen as an early indicator of investor sentiment.

Also Read Upcoming IPOs this week: Indo Farm Equipment IPO and 4 SMEs set to open for subscription – Here are all the details  Upcoming IPOs this week: Unimech Aerospace – a key mainboard and 2 SME IPOs to launch this week Vishal Mega Mart sees a strong debut; lists at 33% premium to issue price on NSE Ventive Hospitality Stock debuts at 12% premium; Details on how the stock is performing after listing?

As per the recent trend, prior to some hours before the official listing of the company, the shares of Senores Pharmaceuticals has been trading at a GMP of Rs 284, suggesting a possible listing price of Rs 675 per share, a 72.63 per cent higher than its upper price band of Rs 391. Furthermore, it is also important to note that over the past two weeks, its GMP has consistently remained strong.

Also Read: Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Check listing price, GMP, allotment status, and other details

On the other side, Ventive Hospitality’s GMP is relatively subdued at Rs 70. This translates to an estimated listing price of Rs 713 per share, which is 10.89 per cent higher than its IPO price of Rs 643.

However, it is important to note that GMP is just an indicator of market sentiment and not a guarantee of the actual listing price or future performance of the stock.

Lot Size

Now coming to the lot size, for retail investors, the minimum investment in the Senores Pharmaceuticals IPO starts at Rs 14,858 for one lot of 38 shares. Small High Net Worth Individuals (sNII) must apply for at least 14 lots,

 » Read More

Related Articles

RIL arm enters hydration category with launch of new Raskik Gluco Energy

Reliance Consumer Products (RCPL), the fast-moving consumer goods arm of Reliance Industries, launched Raskik Gluco Energy on Monday, stepping into the hydration category. The foray will see RCPL take on players such as Tata Consumer Products, which has Tata Gluco Plus, and Dabur, which recently launched Dabur GlucoPlus-C priced at Rs 10 for a 160-ml

SKA Group launches luxury housing project in Wave City, eyes Rs 900-cr topline

The SKA Group has launched its ultra-luxury housing project SKA Divine in Wave City, Ghaziabad. The group intends to invest Rs 150 crore in this project and anticipates generating Rs 900 crore in revenue. Located along the Delhi-Meerut Expressway, the development spans approx. 5 acres, featuring 536 premium apartments across 27 floors in 3 towers

Titan Q3 biz growth at 24 per cent on festive boost

Titan’s standalone business registered a 24% year-on-year growth, the Tata Group company reported on Monday while providing an update for the December 2024 quarter. The company’s jewellery business, in particular, grew 26% year-on-year, driven by strong festive demand. Robust consumer traction during Diwali resulted in high single-digit buyer growth, along with double-digit growth in ticket

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

RIL arm enters hydration category with launch of new Raskik Gluco Energy

Reliance Consumer Products (RCPL), the fast-moving consumer goods arm of Reliance Industries, launched Raskik Gluco Energy on Monday, stepping into the hydration category. The foray will see RCPL take on players such as Tata Consumer Products, which has Tata Gluco Plus, and Dabur, which recently launched Dabur GlucoPlus-C priced at Rs 10 for a 160-ml

SKA Group launches luxury housing project in Wave City, eyes Rs 900-cr topline

The SKA Group has launched its ultra-luxury housing project SKA Divine in Wave City, Ghaziabad. The group intends to invest Rs 150 crore in this project and anticipates generating Rs 900 crore in revenue. Located along the Delhi-Meerut Expressway, the development spans approx. 5 acres, featuring 536 premium apartments across 27 floors in 3 towers

Titan Q3 biz growth at 24 per cent on festive boost

Titan’s standalone business registered a 24% year-on-year growth, the Tata Group company reported on Monday while providing an update for the December 2024 quarter. The company’s jewellery business, in particular, grew 26% year-on-year, driven by strong festive demand. Robust consumer traction during Diwali resulted in high single-digit buyer growth, along with double-digit growth in ticket

D-Street catches HMPV flu

Benchmark equity indices recorded their biggest single-day loss in three months on Monday, as a barrage of bad news hits investor sentiment. Concerns over the human metapneumovirus (HMPV), disappointing Q3 business updates from banks and uncertainties surrounding new US economic policies were the key headwinds. At the same time, the fall in ITC stock due

These 5 stocks are sharply up in a falling market, here’s why…

The markets extended loss and ended in the red for the second straight session. The Sensex fell 1,258 points, or 1.6%, closing the day at 77,965, while the Nifty declined 382.95 points, or 1.6%, ending at 23,621.80. ITC is among the top index losers followed by metals, power and select banks. However, some stocks saw significant